Cyclic MOG₃₅–₅₅ ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis

[img]
Preview
CyclicMOG_BMC_revised.pdf - Accepted Version (2MB) | Preview

Lourbopoulos, A, Deraos, G, Matsoukas, MT, Touloumi, O, Giannakopoulou, A, Kalbacher, H, Grigoriadis, N, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Matsoukas, J (2017) Cyclic MOG₃₅–₅₅ ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 25 (15). 4163 - 4174. ISSN 0968-0896

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/35379
DOI https://doi.org/10.1016/j.bmc.2017.06.005
Official URL https://www.sciencedirect.com/science/article/pii/...
Subjects Current > FOR Classification > 1107 Immunology
Current > Division/Research > College of Health and Biomedicine
Keywords EAE; peptides; myelin oligodendrocyte glycoprotein; proteolipid protein; PLP
Citations in Scopus 13 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login